THE MCMANUS GROUP for GENENTECH
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Reforms related to the 340B program and the pharmaceutical supply chain.
Foreign entity interest: 100% ownership by F. Hoffman-La Roche Ltd., Grenzacherstrasse 124, CH-4070 Basel, SUI
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MCMANUS | — |
| ALANNA TEMME | — |
Medicare/Medicaid MMM
Opposed the International Pricing Index model (83 FR 54546). Medicare Parts B and D reform. Home administration of injectable and infusible drugs including in CMS-1744-IFC and CMS-5531-IFC, as well as H.R. 6218/ S. 3457, the Preserving Patient Access to Home Infusion Act.
Foreign entity interest: 100% ownership by F. Hoffman-La Roche Ltd., Grenzacherstrasse 124, CH-4070 Basel, SUI
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MCMANUS | — |
| ALANNA TEMME | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.